Nanomedicine News

RSS

Particle Sciences and NETZSCH Premier Technologies to Provide Pharmaceutical Nanomilling Equipment

Particle Sciences, a leading drug delivery CRO, has teamed up with NETZSCH Premier Technologies, a leading manufacturer of wet milling and dispersing equipment, to provide drug developers with improved access to state-of-the-art pharmaceutical nanomilling equipment and full pharmaceutical development capabilities.

6 Mar 2013

NanCogenics Co-Founder to Present at BioNanoMed International Conference

Officials at NanCogenics, Inc. announced today that Co-Founder Dr. Jim Klostergaard has been invited to present at the upcoming BioNanoMed 4th International Conference on Nanotechnology, Medicine and Biology, to be held March 13-15, in Krems, Austria.

6 Mar 2013

Nano Labs Proposes Development of Nanoscale Biosensors to Identify Tuberculosis

Nano Labs Corp. is pleased to present industry with promising biological diagnostics test results obtained at macro-level, on a miniaturized tuberculosis biosensor platform.

5 Mar 2013

Diagnostic Gold Nanoparticle Cocktail Can Help Test for Multiple Diseases

A diagnostic ‘cocktail,’ containing a single drop of blood, a dribble of water and a dose of DNA powder with gold particles, could one day lead to the treatment of the world’s leading diseases.

1 Mar 2013

Lipid Nanoparticles Act as Ideal Vectors in Gene Therapy

At the Faculty of Pharmacy of the Basque Public University (UPV/EHU) the Pharmacokinetics, Nanotechnology and Gene Therapy research team is using nanotechnology to develop new formulations that can be applied to drugs and gene therapy.Specifically, they are using nanoparticles todesignsystems for delivering genes and drugs; this helps to get the genes and drugs to the point of action so that they can produce the desired effect.

1 Mar 2013

Theranostic Nanoparticles Make Pinpoint Deliveries of Drug Payloads to Breast Cancer Cells

Tiny particles filled with a drug could be a new tool for treating cancer in the future. A new study published by Swedish scientists in Particle & Particle Systems Characterization shows how such nanoparticles can be combined to secure the effective delivery of cancer drugs to tumour cells - and how they can be given properties to make them visible in MR scanners and thus rendered trackable.

1 Mar 2013

Independent Studies Validate Actium Thermal Nanomedicine Cancer Treatment

Actium BioSystems disclosed today that its novel system platform, ACT, for selectively delivering controlled hyperthermia as an adjuvant to chemotherapy, has been validated via in vivo studies by two independent authorities, including Duke University Medical Center and a contract research facility.

28 Feb 2013

France to be Invited Country at ImagineNano 2013

The organizers of ImagineNano are pleased to announce France as the Invited Country at this year’s edition. Forty French invited speakers among 7 conferences and a pavilion featuring the nanoscience & nanotechn...

28 Feb 2013

CardioNet Partners With Nanoelectronics Research Center to Develop Cardiac Monitoring Products

CardioNet, Inc., the leading wireless medical technology and research services company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, today announced a multi-year development agreement with the Belgium-based nanoelectronics research center IMEC and its Dutch affiliate Holst Centre. Over the next 18 months, the Companies will work to develop two revolutionary cardiac monitoring products.

25 Feb 2013

Zimbabwe Minister Visits UB to Discuss Implementation Strategy for International Nanotechnology Center

The Hon. Professor Heneri Dzinotyiweyi, Zimbabwe minister of science and technology development, visited Buffalo on Feb. 19 to tour two UB research facilities and discuss the vision and implementation strategy for the Zimbabwe International Nanotechnology Center (ZINC) with officials from UB, its primary academic partner.

22 Feb 2013